Besifovir (LB80331), a parent agent converted by LB80380 ( HY-19447A ), further metabolizes to its active form, LB80317 ( HY-106235 ). Besifovir is an orally active, novel antiviral agent against hepatitis B virus ( HBV ) .
Products | Products > Disease Areas > Infection | Products > Disease Areas > Viral Infection | Products > Signaling Pathways > Anti-infection | Products > Research Areas > Infection | Products > Signaling Pathways > HBV
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.